1. Introduction {#sec1-ijerph-17-04164}
===============

The coronavirus disease 2019 (COVID-19) pandemic has caused a huge burden to governments, organizations, and individuals \[[@B1-ijerph-17-04164],[@B2-ijerph-17-04164],[@B3-ijerph-17-04164]\]. According to the report of the World Health Organization on 3 May 2020, the total confirmed cases were 3,349,786, with 238,628 deaths; among these, Vietnam reported 270 cases \[[@B4-ijerph-17-04164],[@B5-ijerph-17-04164]\]. The pandemic causes fear, panic, and mental health problems in the public \[[@B6-ijerph-17-04164],[@B7-ijerph-17-04164],[@B8-ijerph-17-04164]\] and healthcare workers \[[@B9-ijerph-17-04164],[@B10-ijerph-17-04164]\].

During the pandemic, myths and misinformation largely concern the public \[[@B6-ijerph-17-04164],[@B11-ijerph-17-04164],[@B12-ijerph-17-04164]\]. This might affect public's psychological health \[[@B6-ijerph-17-04164],[@B11-ijerph-17-04164],[@B12-ijerph-17-04164]\]. People with a higher degree of health literacy are likely to have a better perception of health information \[[@B13-ijerph-17-04164]\]. Health literacy has been shown as a protective factor of mental health (e.g., depression) in a previous study \[[@B14-ijerph-17-04164]\].

Medical students are future healthcare providers who need comprehensive capacities to improve their self-care and to strengthen patients' autonomy, participation, and self-management abilities \[[@B15-ijerph-17-04164],[@B16-ijerph-17-04164]\]. Public health measures such as quarantine and social distancing are implemented in all countries to contain the spread of COVID-19 \[[@B17-ijerph-17-04164],[@B18-ijerph-17-04164],[@B19-ijerph-17-04164]\]. However, these approaches have negative effects on people's mental health \[[@B20-ijerph-17-04164]\]. The general public is urged to maintain social distancing, work, and study remotely if possible, during the pandemic. Healthcare professionals in the meantime still have to work and continue providing care. They are more likely to have psychological health problems \[[@B21-ijerph-17-04164],[@B22-ijerph-17-04164],[@B23-ijerph-17-04164],[@B24-ijerph-17-04164]\].

Amid the COVID-19 pandemic, all affected countries have mobilized and reallocated resources to respond to the COVID-19 emergency \[[@B25-ijerph-17-04164],[@B26-ijerph-17-04164],[@B27-ijerph-17-04164]\]. Rearrangement of healthcare personnel and changes in how medical students are encouraged which have occurred as part of the pandemic response \[[@B25-ijerph-17-04164],[@B26-ijerph-17-04164],[@B28-ijerph-17-04164],[@B29-ijerph-17-04164]\]. In addition, students who are taking clinical practicum courses might be at a higher risk of infections. Moreover, medical students' mental health has already been demonstrated to a problem worldwide, including in Vietnam, even prior to the pandemic \[[@B30-ijerph-17-04164]\].

Fear of COVID-19 causes healthcare access delays \[[@B8-ijerph-17-04164]\] or even suicide \[[@B31-ijerph-17-04164]\]. To mitigate and contain COVID-19 spread and its unfavorable mental health consequences, it is essential to detect adverse psychological problems (e.g., fear) and implement appropriate interventions at an early stage of their occurrence \[[@B32-ijerph-17-04164],[@B33-ijerph-17-04164]\]. A tool was developed to screen for fear of COVID-19 \[[@B34-ijerph-17-04164]\]. However, this tool has not been validated for use in Vietnam or other countries. Therefore, we aimed to validate the fear of COVID-19 scale (FCoV-19S) and examine, using an online survey, the association of its scores with health literacy and health-related behaviors among medical students at eight universities across Vietnam.

2. Methods {#sec2-ijerph-17-04164}
==========

2.1. Study Design and Settings {#sec2dot1-ijerph-17-04164}
------------------------------

A cross-sectional study was conducted on medical students from 7 to 29 April 2020 using online-based survey questionnaires. Students were recruited from eight universities across Vietnam, including five universities in the North, one university in the Center, and two universities in the South.

2.2. Study Participants {#sec2dot2-ijerph-17-04164}
-----------------------

A total of 5423 medical students participated in the survey, including 510 (15.1%) from Hanoi Medical University, 1197 (39.5%) from Vietnam Military Medical University, 384 (86.5%) from Vietnam National University- School of Medicine and Pharmacy, in Hanoi city; 738 (26.1%) from Thai Nguyen University of Medicine and Pharmacy, in Thai Nguyen Province; 800 (25.4%) from Haiphong University of Medicine and Pharmacy, in Haiphong city; 423 (11.1%) from Hue University of Medicine and Pharmacy, in Thua Thien Hue province; 473 (9.6%) from Pham Ngoc Thach University of Medicine, in Ho Chi Minh city; 898 (13.7%) from Can Tho University of Medicine and Pharmacy, in Can Tho city. The recruitment of the study sample is elucidated in [Figure 1](#ijerph-17-04164-f001){ref-type="fig"}.

2.3. Assessments and Measurements {#sec2dot3-ijerph-17-04164}
---------------------------------

### 2.3.1. Social Demographics and Clinical Indicators {#sec2dot3dot1-ijerph-17-04164}

Students were asked about their age (years), gender (women vs. men), body height (cm), weight (kg). Body mass index (BMI, kg/m^2^) was calculated. They were also asked about their academic year (from year 1 to year 6) and suspected levels of exposure to COVID-19, evaluated as F1 (exposed to a person with confirmed COVID-19), F2 (exposed to F1), F3 (exposed to F2), F4 (exposed to F3), F5 (exposed to F4), to F6 (not suspected), according to the definition of the Ministry of Health in Vietnam \[[@B5-ijerph-17-04164]\]. Students were also asked if the experienced suspected COVID-19 symptoms (S-COVID-19-S) \[[@B35-ijerph-17-04164]\], including common symptoms (fever, cough, dyspnea) and less common symptoms (myalgia, fatigue, sputum production, confusion, headache, sore throat, rhinorrhea, chest pain, hemoptysis, diarrhea, and nausea/vomiting). If students had any of those symptoms, they were classified as having S-COVID-19-S. The Charlson comorbidity index was used to assess comorbidity \[[@B36-ijerph-17-04164],[@B37-ijerph-17-04164]\].

### 2.3.2. Health-Related Behaviors {#sec2dot3dot2-ijerph-17-04164}

Students were asked about their current health-related behaviors as compared with those before the pandemic, including tobacco smoking (never/stop/less vs. unchanged or more), alcohol drinking (never/stop/less vs. unchanged or more), physical activity level (never/stop/less vs. unchanged or more), and eating behavior (less healthy vs. unchanged or healthier).

### 2.3.3. Health Literacy {#sec2dot3dot3-ijerph-17-04164}

Health literacy (HL) was assessed using the short-form HL questionnaire (HLS-SF12) consisting of 12 items. The HLS-SF12 was used as a comprehensive measure of HL for the evaluation of students' ability to access, understand, appraise, and apply health information on healthcare, disease prevention, and health promotion \[[@B38-ijerph-17-04164]\]; it is in agreement with the original framework of comprehensive HL \[[@B39-ijerph-17-04164]\]. In addition, the tool was validated and used in Asian countries \[[@B38-ijerph-17-04164],[@B40-ijerph-17-04164]\], including in Vietnam \[[@B14-ijerph-17-04164],[@B41-ijerph-17-04164],[@B42-ijerph-17-04164]\]. Students responded to each item on 4-point Likert scales from 1 = very difficult to 4 = very easy. The HL index score was standardized to a metric from 0 to 50, using formula (1), with a higher score indicating better HL \[[@B43-ijerph-17-04164]\]: where *Index* is the specific index calculated, *Mean* is the mean of all participating items for each individual, *1* is the minimal possible value of the mean (leading to a minimum value of the index of 0), *3* is the range of the mean, and *50* is the chosen maximum value of the new metric.

### 2.3.4. Fear of COVID-19 {#sec2dot3dot4-ijerph-17-04164}

The fear of COVID-19 as an immediate consequence of the pandemic was assessed using the FCoV-19S, which is reliable and valid in assessing COVID-19 fear among the general population \[[@B34-ijerph-17-04164]\]. The questionnaire was translated into Vietnamese by researchers. The content was then validated by an expert panel (one psychiatrist, 10 medical doctors, 7 nurses, and 5 public health professionals). The expert panel suggested keeping the original rating scale and scoring. The tool consists of 7 items evaluated on a 5-point Likert scale, with 1 = "strongly disagree", 2 = "disagree", 3 = "neither disagree or agree", 4 = "agree", 5 = "strongly agree". The total score is the sum of the scores of the 7 items, ranging from 7 to 35, with a higher score indicating greater fear of COVID-19.

In addition, anxiety disorder was assessed using the Generalized Anxiety Disorder scale with seven items (GAD-7) \[[@B44-ijerph-17-04164]\]. The tool was validated and used in Vietnam \[[@B45-ijerph-17-04164]\]. Students were asked about how often (during the last 2 weeks) they experienced seven symptoms based on a 4-point Likert scale, with 0 = "not at all", 1 = "several days", 2 = "more than half the days", 3 = "nearly every day". The total GAD-7 score ranges from 0 to 21. Students were classified as having anxiety disorder if they had a GAD-7 score ≥8 \[[@B46-ijerph-17-04164],[@B47-ijerph-17-04164]\].

2.4. Data Collection Procedure {#sec2dot4-ijerph-17-04164}
------------------------------

We purposely selected 5 public universities in the North, 1 public university in the Center, and 2 public universities in the South of Vietnam. Medical students were invited and encouraged to participate in the survey by lecturers of the university. Researchers (lecturers) at each university sent the online survey link to the contact students of each class via email, Messenger, or Zalo. The link was then sent to other students. The students voluntarily took the survey. It took about 5 min to complete the survey questionnaires. All questions on the online survey were mandatory; therefore, there are no missing data in our study. The collected data were coded, cleaned, and analyzed by researchers confidentially.

2.5. Data Analysis {#sec2dot5-ijerph-17-04164}
------------------

Firstly, the distribution of the studied variables was explored using descriptive analysis. Mean, standard deviation, or percentages were reported appropriately.

*Construct validity:* To examine the construct of the FCoV-19 scale, principal component analysis (PCA) was used. The Kaiser--Meyer--Olkin Measure of Sampling Adequacy (KMO) was used to determine the suitability of the data for component analyses and was set to be greater than 0.60, while the Bartlett's Test of Sphericity value was set to be less than 0.05 \[[@B48-ijerph-17-04164]\]. One component representing the unidimensional scale of FCoV-19S was retained, while the oblique rotation (Promax) method was used. Factor loadings of seven items of the FCoV-19 scale and percentage of variance were reported.

*Convergent validity:* The correlation between the FCoV-19 scale's scores and its seven items was determined by the Spearman's correlation coefficient.

*Discriminant validity:* Anxiety disorder was used to evaluate the discriminant validity of the FCoV-19S. A receiver operating characteristic (ROC) curve analysis was run with anxiety (GAD ≥ 8) as the reference to estimate the area under the ROC curve (AUC).

*Reliability analysis:* The Cronbach's alpha test was used to assess the internal consistency, with satisfactory reliability corresponding to a value ≥0.70 \[[@B49-ijerph-17-04164]\].

*Floor and ceiling effects of the FCoV-19 scale:* The percentages of respondents who scored the lowest score or the highest score were calculated. The minimal floor and ceiling effects (\<15%) were recommended \[[@B50-ijerph-17-04164]\].

*Associations between FCoV-19 and other factors:* One-way ANOVA test was used to compare the distribution of FCoV-19S scores between categories of the studied variables. In addition, simple and multiple linear regression models were utilized to examine the predictors of fear of COVID-19. The factors that were included in the multiple regression analysis were those that showed association with FCoV-19S scores at *p* \< 0.20 in the simple regression model \[[@B51-ijerph-17-04164]\]. The regression coefficient (B) and 95% confidence interval (95%CI) were reported. Furthermore, the associations between FCoV-19S scores and health-health related behaviors were examined using simple and multiple logistic regression models. The odds ratio (OR) and 95%CI were reported.

Data were analyzed using the IBM SPSS Version 20.0 (IBM Corp, Armonk, NY, USA). The significance level was set at *p* \< 0.05.

2.6. Ethical Consideration {#sec2dot6-ijerph-17-04164}
--------------------------

The study protocol was approved by the Institutional Ethical Review Committee of Hanoi School of Public Health, Vietnam (IRB No. 133/2020/YTCC-HD3). The consent form was obtained from the students before their participation.

3. Results {#sec3-ijerph-17-04164}
==========

3.1. Participants' Characteristics {#sec3dot1-ijerph-17-04164}
----------------------------------

The average age of the students was 22.0 ± 2.0. Of all, 47.9% were men; for 53.9% of the students it was very or fairly easy to pay for their necessary medications. The prevalence of underweight and overweight/obese was 17.4% and 8.2%, respectively. In addition, 18.9% of the students presented with suspected COVID-19 symptoms. The proportions of students eating, smoking, drinking, or exercising at an 'unchanged or higher level were 93.0%, 3.1%, 6.95%, or 68.1%, respectively ([Table 1](#ijerph-17-04164-t001){ref-type="table"}).

3.2. Psychometric Properties of FCoV-19 {#sec3dot2-ijerph-17-04164}
---------------------------------------

The KMO value for the whole scale was 0.86, while, for individual items, the values ranged from 0.77 to 0.94 and were above the acceptable limit of 0.50. The Bartlett's Test of Sphericity value was less than 0.001, at a satisfactory level.

Seven items were loaded on one component with the percentage of variance of 62.15%. The factor loadings of seven items are shown in [Table 2](#ijerph-17-04164-t002){ref-type="table"}. The average communality value of 0.62 was at an adequate level, demonstrating the accuracy of the approach \[[@B52-ijerph-17-04164]\].

The correlations between each item and the scale ranged from 0.66 to 0.84. In addition, the AUC was 0.63 (0.60--0.66), thus larger than 0.50 ([Table 2](#ijerph-17-04164-t002){ref-type="table"}; [Figure 2](#ijerph-17-04164-f002){ref-type="fig"}). This indicates satisfactory discrimination validity of the FCoV-19S \[[@B53-ijerph-17-04164]\].

The reliability was at a high level, with Cronbach's alpha value of 0.90. There were no significant floor or ceiling effects, with 8.20% of the participants at the lowest potential response, and 0.40% at the highest potential response, which were less than 15% ([Table 2](#ijerph-17-04164-t002){ref-type="table"}).

3.3. Factors Associated with FCoV-19 {#sec3dot3-ijerph-17-04164}
------------------------------------

The score of fear of COVID-19 significantly varied by categories of age, gender, ability to pay for medication, BMI, academic year, smoking, drinking, and anxiety ([Table 1](#ijerph-17-04164-t001){ref-type="table"}). The results in [Table 3](#ijerph-17-04164-t003){ref-type="table"} show that older age (23--26 years), being men, great or fair easiness to pay for medication, later academic years, higher health literacy score were significantly negatively associated with FCoV-19S scores, whereas smoking or drinking at an unchanged or higher level was positively associated with the FCoV-19S scores in the bivariate model. To avoid multicollinearity, correlation among the covariates was checked. A strong correlation between age and academic year (rho = 0.84) was found ([Table S1](#app1-ijerph-17-04164){ref-type="app"}). We selected age in the multivariate analysis together with other covariates that were associated with FCoV-19S at *p* \< 0.20. The results showed that age of 23--26 years (coefficient, B, −0.96; 95% confidence interval, 95%CI, −1.24, −0.67; *p* \< 0.001), being men (B, −0.68; 95%CI, −0.97, −0.38; *p* \< 0.001), great or fair easiness to pay for medication (B, −0.45; 95%CI, −0.73, −0.17; *p* \< 0.002), higher health literacy (B, −0.06; 95%CI, −0.08, −0.04; *p* \< 0.001; [Table 3](#ijerph-17-04164-t003){ref-type="table"}) had lower scores on the FCoV−19S as compared to their respective counterparts. The adjusted R-square was 0.022.

Finally, the students with higher FCoV-19S scores were more likely to be smoking at an unchanged or higher level (odds ratio, OR, 1.11; 95% CI, 1.08, 1.14; *p* \< 0.001) and drinking at an unchanged or higher level (OR, 1.04; 95% CI, 1.02, 1.06; *p* \< 0.001; [Table 4](#ijerph-17-04164-t004){ref-type="table"}). In other words, a 1-point increment of the FCoV-19S score was associated with an 11% or 4% greater likelihood of smoking or drinking at the same or higher level, respectively. In addition, results of the Hosmer and Lemeshow test of the goodness of fit in multiple logistic regression models showed *p*-values of 0.64 (for eating behavior), 0.07 (for smoking behavior), 0.47 (for drinking behavior), and 0.11 (for exercise), which were all larger than 0.05. This indicates that the models well fit the data \[[@B53-ijerph-17-04164]\].

4. Discussion {#sec4-ijerph-17-04164}
=============

The results of our study show that the fear of COVID-19 scale is a unidimensional, valid, and reliable survey tool to assess the fear of students during the COVID-19 pandemic. The tool demonstrates higher values of factor loadings, item--scale convergent validity, internal consistency, and better floor and ceiling effects in the current study than that in a previous study \[[@B34-ijerph-17-04164]\].

Students at older age and later academic year had lower scores of fear than those at younger age and earlier academic year. This could be explained by the fact that senior students had a better knowledge about the disease, medical skills, and prevention measures than junior ones, which could further protect them from fear of COVID-19. In addition, male students reported a lower score of fear as compared with female students. This might be explained by the fact that women usually sustain a greater burden than men during a pandemic, including house works, caregiving role, or domestic violence \[[@B54-ijerph-17-04164]\]. In addition, women usually suffer from more stressful life events than men \[[@B55-ijerph-17-04164],[@B56-ijerph-17-04164]\]. Previous studies illustrated that the prevalence of anxiety and depression of graduate female students was higher than that of male students \[[@B57-ijerph-17-04164],[@B58-ijerph-17-04164]\]. It suggests that universities should have a strategic approach to protect the mental health of students, with additional focus on that of female students \[[@B57-ijerph-17-04164],[@B59-ijerph-17-04164]\].

In the current study, students with a greater ability to pay for necessary medication and healthcare services had a lower score of fear. This agrees with a previous study which demonstrated that college students with family income stability had a lower likelihood of psychological problems during the COVID-19 pandemic \[[@B60-ijerph-17-04164]\].

The results of the current study show that students with a higher score of fear are more likely to smoke or drink. The finding is in line with a previous study reporting that mental disorders were a risk factor for substance use, abuse, and dependence \[[@B61-ijerph-17-04164]\]. In addition, a previous study of 41 low--middle-income countries showed that people with a higher stress level had a higher likelihood of smoking \[[@B62-ijerph-17-04164]\]. Furthermore, cigarette smoking was found to help to ease negative emotions in unpleasant events \[[@B62-ijerph-17-04164],[@B63-ijerph-17-04164]\]. Additionally, alcohol drinking can temporarily help to reduce tension, and stress \[[@B64-ijerph-17-04164]\]. Importantly, lifestyle factors demonstrated a significant association with the clinical course of COVID-19 \[[@B65-ijerph-17-04164],[@B66-ijerph-17-04164]\]. Therefore, strategic public health interventions are needed to reduce fear and reduce substance use or abuse among medical students, which might further protect their health.

Finally, health literacy showed a protective effect on fear in our study. Health literacy has been recognized as a critical skill in evaluating online health information \[[@B67-ijerph-17-04164]\], especially in our digital world characterized by diverse information and sources \[[@B68-ijerph-17-04164]\]. Besides, higher health literacy was associated with a better health status \[[@B69-ijerph-17-04164],[@B70-ijerph-17-04164]\], reduced health inequities, and improved health and well-being \[[@B71-ijerph-17-04164],[@B72-ijerph-17-04164]\]. Furthermore, a previous study showed that health literacy can help to protect people's mental health and improve quality of life during the COVID-19 pandemic \[[@B14-ijerph-17-04164]\]. Therefore, enhancing medical students' health literacy skills is considered a strategic approach to reducing fear and improving their health and wellbeing. It is important for people, especially healthcare workers, to have adequate possibility to access, analyze, and apply health information during the COVID-19 pandemic to protect their own health and that of people they take care of. Therefore, health literacy should be seen as a key element of social responsibility and solidity and an essential tool for both information receivers and providers in order to mitigate and contain the current pandemic and potential future ones \[[@B73-ijerph-17-04164]\]. An interdisciplinary approach to improving health literacy is more important before than during a pandemic \[[@B74-ijerph-17-04164]\].

The current study has some limitations. Firstly, the survey was conducted online, and we could not diagnose any psychological disorder in the students (e.g., anxiety or depression), which would have help to check the sensitivity and specificity of the FCoV-19 scale. Secondly, causality cannot be drawn from this study, which used a cross-sectional design. Thirdly, test--retest reliability could not be assessed because of the nature of the study design. This is similar to a previous study conducted in China with limited resources and the urgent need of the evidence during COVID-19 pandemic \[[@B75-ijerph-17-04164]\]. We surveyed a large sample of students at eight universities across Vietnam, but the study sample was not randomly selected. Therefore, the finding should be generalized to medical students with caution. Furthermore, the low R-square value (0.02 or 2%) and the relatively low AUC value (0.63) may indicate that the predictive capability of these models is limited and other variables not included in this study may increase it. Future studies are required to address the above-mentioned limitations. Despite these limitations, our findings help describe the phenomenon of the current pandemic, raise hypotheses for further research related to fear and lifestyle changes during pandemics, and suggest means to increase preparedness for possible future pandemics.

5. Conclusions {#sec5-ijerph-17-04164}
==============

The current study shows that the fear of COVID-19 scale is a valid and reliable tool to screen for fear among medical students in Vietnam. Factors such as older age or later academic year, being male, a greater ability to pay for medication, and a higher degree of health literacy may protect medical students from fear during the pandemic. In addition, students with a higher score of fear more likely had unhealthy lifestyles, such as smoking and drinking alcohol. Strategic public health interventions are suggested to reduce fear and promote healthy lifestyles which may further protect students' health and wellbeing.
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###### 

Participants' characteristics and scores on the fear of COVID-19 scale (FCoV-19S).

  -----------------------------------------------------------------------------
  Variables                             Total\         FCoV-19S\      
                                        (*n* = 5423)   (*n* = 5423)   
  ------------------------------------- -------------- -------------- ---------
  Age, year                                                           \<0.001

   19--22                               3162 (58.3)    17.0 ± 5.3     

   23--26                               2261 (41.6)    16.0 ± 5.1     

  Gender                                                              \<0.001

   Women                                2821 (52.0)    17.0 ± 4.8     

   Men                                  2602 (47.9)    16.2 ± 5.6     

  Ability to pay for medication                                       \<0.001

   Very or fairly difficult             2496 (46.0)    16.9 ± 5.3     

   Very or fairly easy                  2927 (53.9)    16.4 ± 5.1     

  BMI, kg/m^2^                                                        0.018

   Underweight (BMI \< 18.5)            945 (17.4)     17.0 ± 4.8     

   Normal weight (18.5 ≤ BMI \< 25.0)   4034 (74.3)    16.5 ± 5.3     

   Overweight/obese (BMI ≥ 25.0)        444 (8.2)      16.7 ± 5.5     

  Academic year                                                       \<0.001

   1                                    1171 (21.5)    17.0 ± 5.3     

   2                                    773 (14.2)     17.3 ± 5.5     

   3                                    762 (14.0)     17.2 ± 5.2     

   4                                    738 (13.6)     16.9 ± 5.2     

   5                                    920 (16.9)     15.9 ± 5.2     

   6                                    1059 (19.5)    15.8 ± 4.9     

  S-COVID-19-S \*\*                                                   0.186

   No                                   4396 (81.0)    16.6 ± 5.3     

   Yes                                  1027 (18.9)    16.8 ± 5.0     

  Comorbidity                                                         0.768

   None                                 5180 (95.5)    16.6 ± 5.2     

   One or more                          243 (4.5)      16.5 ± 5.2     

  Eating behavior \*\*\*                                              0.205

   Eat less healthy                     377 (7.0)      16.9 ± 5.4     

   Unchanged or healthier               5046 (93.0)    16.6 ± 5.2     

  Smoking \*\*\*                                                      \<0.001

   Never, stopped, or smoke less        5255 (96.9)    16.5 ± 5.1     

   Unchanged or smoke more              168 (3.1)      19.4 ± 7.6     

  Drinking alcohol \*\*\*                                             0.001

   Never, stopped, or drink less        5048 (93.0)    16.5 ± 5.1     

   Unchanged or drink more              375 (6.9)      17.5 ± 6.7     

  Physical activity \*\*\*                                            0.599

   Never, stopped, or exercise less     1728 (31.8)    16.6 ± 5.4     

   Unchanged or exercise more           3695 (68.1)    16.6 ± 5.1     

  Anxiety                                                             \<0.001

   GAD \< 8                             5007 (92.3)    16.4 ± 5.1     

   GAD ≥ 8                              416 (7.7)      19.3 ± 6.3     

  FCoV-19, mean ± SD                    16.7 ± 5.3                    

  HL index, mean ± SD                   34.7 ± 7.0                    
  -----------------------------------------------------------------------------

Abbreviations: BMI, body mass index; COVID-19, coronavirus disease 2019; S-COVID-19-S, suspected coronavirus disease 2019 symptoms; FCoV-19S, fear of coronavirus disease 2019 scale; GAD, generalized anxiety disorder; SD, standard deviation; HL, health literacy. \* Result of One-Way ANOVA test. \*\* Suspected COVID-19 symptoms including common symptoms (fever, cough, dyspnea), less common symptoms (myalgia, fatigue, sputum production, confusion, headache, sore throat, rhinorrhea, chest pain, hemoptysis, diarrhea, and nausea/vomiting). \*\*\* People were asked whether their lifestyles were worse, better, or unchanged during the COVID-19 pandemic as compared to those before the pandemic.
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###### 

Construct and convergent validity, internal consistency, and floor and ceiling effects of the FCoV-19 scale (*n* = 5423).

  Items                                                                                             FCoV-19 Scale
  ------------------------------------------------------------------------------------------------- -------------------
  1\. I am most afraid of COVID-19.                                                                 0.84
  2\. It makes me uncomfortable to think about COVID-19.                                            0.83
  3\. My hands become clammy when I think about COVID-19.                                           0.81
  4\. I am afraid of losing my life because of COVID-19.                                            0.81
  5\. When watching news and stories about COVID-19 on social media, I become nervous or anxious.   0.78
  6\. I cannot sleep because I'm worrying about getting COVID-19.                                   0.76
  7\. My heart races or palpitates when I think about getting COVID-19.                             0.69
  Percentage of variance, %                                                                         62.15
  Item--scale convergent validity, mean of Rho (range)                                              0.77 (0.66--0.84)
  AUC (95%CI), GAD ≥ 8 as the reference                                                             0.63 (0.60--0.66)
  Internal consistency, Cronbach's alpha                                                            0.90
  Floor effects, %                                                                                  8.20
  Ceiling effect, %                                                                                 0.40

Abbreviations: Rho, Spearman's correlation coefficient; AUC, area under the receiver operating characteristic curve; CI, confidence interval.
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###### 

Predictors of the fear of COVID-19 (*n* = 5423).

  Variables                             FCoV-19S                                                
  ------------------------------------- ---------------------- --------- ---------------------- ---------
  Age, year                                                                                     
   19--22                               0.00                             0.00                   
   23--26                               −1.02 (−1.31, −0.74)   \<0.001   −0.96 (−1.24, −0.67)   \<0.001
  Gender                                                                                        
   Women                                0.00                                                    
   Men                                  −0.71 (−0.99, −0.43)   \<0.001   −0.68 (−0.97, −0.38)   \<0.001
  Ability to pay for medication                                                                 
   Very or fairly difficult             0.00                                                    
   Very or fairly easy                  −0.55 (−0.83, −0.26)   \<0.001   −0.45 (−0.73, −0.17)   0.002
  BMI, kg/m^2^                                                                                  
   Underweight (BMI \< 18.5)            0.54 (0.16, 0.91)      0.005     0.29 (−0.09, 0.67)     0.133
   Normal weight (18.5 ≤ BMI \< 25.0)   0.00                                                    
   Overweight/obese (BMI ≥ 25.0)        0.21 (−0.31, 0.73)     0.421     0.48 (−0.04, 1.00)     0.069
  Academic year                                                                                 
   1                                    0.00                                                    
   2                                    0.31 (−0.17, 0.79)     0.203                            
   3                                    0.23 (−0.25, 0.71)     0.349                            
   4                                    −0.02 (−0.50, 0.46)    0.933                            
   5                                    −1.10 (−1.56, −0.65)   \<0.001                          
   6                                    −1.18 (−1.62, −0.74)   \<0.001                          
  S-COVID-19-S \*\*                                                                             
   No                                   0.00                                                    
   Yes                                  0.24 (−0.12, 0.6)      0.186     0.07 (−0.29, 0.43)     0.708
  Comorbidity                                                                                   
   None                                 0.00                                                    
   One or more                          −0.1 (−0.78, 0.58)     0.768                            
  HL index, 1-score increment           −0.07 (−0.09, −0.05)   \<0.001   −0.06 (−0.08, −0.04)   \<0.001

Abbreviations: B, regression coefficient; \* Results of simple and multiple linear regression models. \*\* Suspected COVID-19 symptoms including common symptoms (fever, cough, dyspnea), less common symptoms (myalgia, fatigue, sputum production, confusion, headache, sore throat, rhinorrhea, chest pain, hemoptysis, diarrhea, and nausea/vomiting).
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###### 

Association between fear of COVID-19 and lifestyles analyzed via logistic regression models (*n* = 5423).

  FCoV-19S \*   Unchanged or Eat Healthier \*\*   Unchanged or Smoke More \*\*   Unchanged or Drinking More \*\*   Unchanged or Exercise More \*\*                                                  
  ------------- --------------------------------- ------------------------------ --------------------------------- --------------------------------- ------------------- --------- ---------------- -------
  Model 1       0.99 (0.97, 1.01)                 0.205                          1.11 (1.08, 1.14)                 \<0.001                           1.03 (1.01, 1.06)   0.001     1 (0.99, 1.01)   0.599
  Model 2       0.99 (0.97, 1.01)                 0.211                          1.11 (1.08, 1.14)                 \<0.001                           1.04 (1.02, 1.06)   \<0.001   1 (0.99, 1.01)   0.608

Abbreviations: OR, odds ratio. \* The association between FCoV-19S scores and lifestyle indicators by 1-point increments. \*\* The reference groups are 'Eat less healthily', 'Never, stopped, or smoke less', 'Never, stopped, or drink less', 'Never, stopped, or exercise less', appropriately. Model 1: Association between FCoV-19S scores and lifestyles. Model 2: Adjusted for age, gender, ability to pay for medication, and health literacy.
